Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

Published:2020-10-28 Issue:5 Volume:70 Page:1177-1188
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Brozos-Vázquez Elena María,Díaz-Peña Roberto,García-González Jorge,León-Mateos Luis,Mondelo-Macía Patricia,Peña-Chilet María,López-López Rafael

Funder

Liquid Biopsy Crowdfunding campaign

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02752-z.pdf

Reference70 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

2. Houston KA, Henley SJ, Li J et al (2014) Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer (Amsterdam, Netherlands) 86:22–28. https://doi.org/10.1016/j.lungcan.2014.08.001

3. Doroshow DB, Herbst RS (2018) Treatment of advanced non-small cell lung cancer in 2018. JAMA Oncol 4:569. https://doi.org/10.1001/jamaoncol.2017.5190

4. Barlesi F, Mazieres J, Merlio J-P et al (2016) Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet (Lond, Engl) 387:1415–1426. https://doi.org/10.1016/S0140-6736(16)00004-0

5. Muinelo-Romay L, García-González J, León-Mateos L (2019) Lung cancer and liquid biopsy: realities and challenges in routine clinical practice. Arch Bronconeumol 55:289–290. https://doi.org/10.1016/j.arbres.2018.11.011

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

2. Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer;Clinical and Experimental Medicine;2024-07-18

3. Unveiling the landscape of pathomics in personalized immunotherapy for lung cancer: a bibliometric analysis;Frontiers in Oncology;2024-07-08

4. Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?;Journal of Cancer Research and Clinical Oncology;2024-06-26

5. Oleandrin enhances radiotherapy sensitivity in lung cancer by inhibiting the ATM/ATR‐mediated DNA damage response;Phytotherapy Research;2024-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3